STAT News – Biotech
Opinion: Future physicians need more nutrition education — but not of the MAHA variety
After decades of research, there is little doubt that nutrition plays a critical role in promoting health across the lifespan. This is especially true among vulnerable populations (infants and young children, pregnant people, the aged, and the food insecure) but also among otherwise healthy people. The well-documented rising tide of obesity has been associated not only with heart disease, diabetes, and cancer, but with a drop in U.S. life expectancy. It is estimated that, based on measures of blood glucose, lipids, and other parameters, less than 12% of the adult American population can even be said to metabolically healthy.
It is against this backdrop that we applaud, on its face, the recent directive from U.S. Secretaries Linda McMahon and Robert F. Kennedy Jr. to promote nutrition education across medical training. There will undoubtedly be many benefits to a physician workforce with a strong, scientifically grounded understanding of nutrition. But are all of the “Make America Healthy Again” nutrition recommendations truly science-based?”
STAT News – Biotech
STAT+: Amid focus on food, FDA leader briefs lawmakers on priorities
WASHINGTON — Food and Drug Administration officials briefed senators on the agency’s plans for food policy for 2026, according to a person familiar with the meeting.
The agency plans to focus on infant formula safety, updating food labels, defining ultra-processed foods, expanding inspections of food processing plants, and bolstering seafood safety programs, according to a document shared with lawmakers, obtained by STAT.
The meeting comes amid a shift in the administration’s health agenda toward food issues and away from vaccine policy. In recent polls, food reforms have been more popular than the vaccine agenda, catching the attention of administration officials looking to sharpen their message for the midterms.
STAT News – Biotech
STAT+: In private meetings, White House works to win pharma companies’ support for drug pricing bill
WASHINGTON — The White House has drafted legislative text for its drug pricing policy, and officials are in the process of sharing it with more than a dozen major pharmaceutical companies, according to people familiar with the meetings.
The legislative text, according to a White House official, closely follows the outlines of the voluntary deals the administration made with pharma companies. The draft includes a policy that would allow drugs purchased in cash to count toward a patient’s deductible.
The Trump administration’s push for drug price legislation is part of a larger effort to get health reforms signed into law. The president’s focus on his affordability agenda in an election year has heightened the profile of the effort.
STAT News – Biotech
STAT+: China’s biotech boom is rewriting everything
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The NIH’s foreign subaward crackdown is scrambling global collaborations, while China’s rapid ascent is reshaping drug development. Meanwhile, Wave Life Sciences sheds half its value on underwhelming obesity results.
Also, breaking: I’m adopting a rogue backyard tortoise and will name it Philbert.
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Contributors9 years agoThe final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years agoAccording to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years agoThe old and New Edition cast comes together to perform
-
Uncategorized9 years agoPhillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years agoUber and Lyft are finally available in all of New York State
-
Uncategorized9 years agoDisney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoSteph Curry finally got the contract he deserves from the Warriors